These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 10391689)
21. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Kim JW; Namkoong SE; Ryu SW; Kim HS; Shin JW; Lee JM; Kim DH; Kim IK Gynecol Oncol; 1998 Jul; 70(1):75-9. PubMed ID: 9698478 [TBL] [Abstract][Full Text] [Related]
22. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes. Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616 [TBL] [Abstract][Full Text] [Related]
23. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas. Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133 [TBL] [Abstract][Full Text] [Related]
24. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma. Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966 [TBL] [Abstract][Full Text] [Related]
25. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193 [TBL] [Abstract][Full Text] [Related]
26. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
27. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma. Merbs SL; Sidransky D Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984 [TBL] [Abstract][Full Text] [Related]
28. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. Tanaka T; Kondo S; Iwasa Y; Hiai H; Toyokuni S Am J Pathol; 2000 Jun; 156(6):2149-57. PubMed ID: 10854235 [TBL] [Abstract][Full Text] [Related]
29. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Li YJ; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R Oncogene; 1995 Aug; 11(3):597-600. PubMed ID: 7630644 [TBL] [Abstract][Full Text] [Related]
30. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors. Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215 [TBL] [Abstract][Full Text] [Related]
31. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
32. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003 [TBL] [Abstract][Full Text] [Related]
33. Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. Zhong Y; Onuki J; Yamasaki T; Ogawa O; Akatsuka S; Toyokuni S Carcinogenesis; 2009 Jan; 30(1):158-64. PubMed ID: 19028700 [TBL] [Abstract][Full Text] [Related]
34. Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Hiroyasu M; Ozeki M; Kohda H; Echizenya M; Tanaka T; Hiai H; Toyokuni S Am J Pathol; 2002 Feb; 160(2):419-24. PubMed ID: 11839561 [TBL] [Abstract][Full Text] [Related]
35. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia. Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092 [TBL] [Abstract][Full Text] [Related]
37. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830 [TBL] [Abstract][Full Text] [Related]
38. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182 [TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. Bazan V; Zanna I; Migliavacca M; Sanz-Casla MT; Maestro ML; Corsale S; Macaluso M; Dardanoni G; Restivo S; Quintela PL; Bernaldez R; Salerno S; Morello V; Tomasino RM; Gebbia N; Russo A J Cell Physiol; 2002 Sep; 192(3):286-93. PubMed ID: 12124774 [TBL] [Abstract][Full Text] [Related]
40. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas. Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]